Indian drugmaker Ranbaxy still has exclusive rights for Nexium generic: CEO

MUMBAI (Reuters) - Indian drugmaker Ranbaxy Laboratories still has exclusive rights to the launch of AstraZeneca's heartburn drug Nexium in the United States, it said on Tuesday, despite regulatory concern over the manufacturing process.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news